CTSO - CIK 0001175151
The table below shows Cytosorbents Corp's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $4.81M | $7.54M | $10.20M | $11.59M | $5.69M | $8.46M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $7.15M | $7.43M | $7.74M | $7.67M | $6.63M | $7.82M |
| Inventory | $4.48M | $4.00M | $3.71M | $3.02M | $3.25M | $4.32M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $17.76M |
| $21.31M |
| $22.99M |
| $25.41M |
| $16.60M |
| $21.96M |
| Property, plant & equipment | $7.51M | $8.19M | $8.47M | $8.72M | $9.27M | $9.42M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $40.56M | $45.75M | $47.99M | $50.78M | $47.80M | $53.43M |
| Accounts payable | $3.13M | $3.04M | $3.39M | $3.33M | $2.34M | $3.05M |
| Total current liabilities | $16.30M | $10.11M | $9.84M | $9.74M | $8.43M | $10.34M |
| Long-term debt | $10.31M | $14.57M | $14.38M | $14.19M | $13.81M | $13.67M |
| Total liabilities | $38.37M | $36.73M | $36.40M | $36.24M | $34.80M | $36.69M |
| Retained earnings | -$317.34M | -$306.71M | -$303.54M | -$305.49M | -$295.34M | -$293.01M |
| Total equity | $2.19M | $9.02M | $11.59M | $14.54M | $13.00M | $16.74M |